• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
J Neurosci. Author manuscript; available in PMC Jul 13, 2010.
Published in final edited form as:
PMCID: PMC2826174
NIHMSID: NIHMS172342

Olfactory Dysfunction Correlates with Amyloid-β Burden in an Alzheimer’s Disease Mouse Model

Abstract

Alzheimer’s disease often results in impaired olfactory perceptual acuity–a potential biomarker of the disorder. However, the utility of olfactory screens to serve as informative indicators of Alzheimer’s is precluded by a lack of knowledge regarding why the disease impacts olfaction. We addressed this question by assaying olfactory perception and amyloid β (Aβ) deposition throughout the olfactory system in mice which overexpress mutated form of the human amyloid β precursor protein. Such mice displayed progressive olfactory deficits which mimic those observed clinically some evident upon 3 months of age. Also at 3 months of age we observed non-fibrillar Aβ deposition within the olfactory bulb earlier than deposition within any other brain region. There was also a correlation between olfactory deficits and the spatial-temporal pattern of Aβ deposition. Therefore, non-fibrillar, versus fibrillar Aβ-related mechanisms likely contribute to early olfactory perceptual loss in Alzheimer’s disease. Further, these results present the odor cross-habituation test as a powerful behavioral assay which reflects Aβ deposition and thus may serve to monitor the efficacy of therapies aimed at reducing Aβ.

Keywords: Amyloid-β, biomarker, piriform cortex, olfactory bulb, behavioral models, Neuropathology

Introduction

Alzheimer’s disease (AD) is a progressively debilitating brain disease wherein patients suffer from sensory, motor and cognitive loss. Currently, much interest exists in establishing methods to diagnose AD prior to the irreversible deterioration of the brain characteristic of the disease. One potential avenue in the early diagnosis of AD is the use of olfactory sensory dysfunction in combination with neuropsychological measures (Murphy, 1999; Albers et al., 2006). Persons displaying AD often have a reduced ability to detect, discriminate, and identify odors (for review (Mesholam et al., 1998; Murphy, 1999)). However, the utility of olfactory screens to serve as an informative biomarker for AD is precluded by a lack of knowledge regarding why AD impacts olfaction. Understanding the relationship between AD neuropathological progression and the occurrence of atypical olfactory perception will be an important step forward in this quest.

AD is pathologically defined by the presence of amyloid β (Aβ) plaques and neurofibrillary tangles (NFTs) within the brain. Plaques are mostly composed of Aβ which derives from APP (amyloid β precursor protein). NFTs are made of hyper-phosphorylated forms of the microtubule-associated protein tau. Together the presence of these markers represents the classic diagnostic hallmarks of AD (Alzheimer et al., 1907). Models of AD-related tauopathy and amyloidosis are well established as contributing to our understanding of the physiological and cognitive aspects of the disease (Lee et al., 2001; Hardy and Selkoe, 2002). Currently though, neither model has been directly tested in relation to understanding the cause of olfactory dysfunction in AD.

The mechanisms of AD-related olfactory sensory loss can be uniquely explored through the use of APP transgenic mouse models (Van Dijck et al., 2008; Zhuo et al., 2008; Guérin et al., 2009; Montgomery et al., 2009; Young et al., 2009). The neural mechanisms of odor processing in rodents are relatively understood. Olfaction involves processing stages spanning from sensory neuron input to the olfactory bulb, decoding and plasticity in the piriform cortex, and ultimately down-stream neurons in the hippocampus (Wachowiak and Shipley, 2006; Wilson and Stevenson, 2006). While studies exist showing olfactory-behavior deficits in APP transgenic mice (odor reversal learning, odor memory, etc.) (Van Dijck et al., 2008; Zhuo et al., 2008; Guérin et al., 2009; Montgomery et al., 2009; Young et al., 2009), no studies are available directly relating Aβ in the olfactory system with olfactory perceptual loss. The extent of Aβ pathology across this system and the involvement of these regions in AD-related olfactory sensory deficits remains largely unexplored (but see (Price et al., 1991; Kovacs, 2004)). Further, despite the fundamental role of Aβ in modulating neural processing (Selkoe, 2008), whether Aβ plays a role in contributing to AD-related atypical olfactory behaviors is unknown.

Here we addressed the relationship between Aβ deposition within olfactory processing networks and odor perception in the Tg2576 AD mouse model (Hsiao et al., 1996) at sequential life stages. We found evidence to suggest that olfactory deficits in AD may stem from deposition of non-fibrillar Aβ within the first synaptic processing stage of the olfactory system.

Materials & Methods

Mice

Mice bred and maintained within the Nathan S. Kline Institute for Psychiatric Research animal facility were used. Tg2576 mice were generated previously by overexpressing the 695-amino acid isoform of human APP containing the KM670/671NL mutation, as described (Hsiao et al., 1996). Age-matched non-transgenic (WT) mice on B6SJLF1/J background were used as controls. To examine the possible contributions of accumulating Aβ pathology throughout life on olfaction we used four separate age-groups: 3–4 months old (Tg n=5, 5 male and WT n=6, 2 female, 4 male), 6–7 months old (Tg n=5, 3 female, 2 male and WT n=4, 2 female, 2 male), 16 months old (Tg n=6, 6 male and WT n=9, 9 male) and 21–29 months old mice (mean ± SEM: 23.5±0.6; Tg n=6, 2 female, 4 male and WT n=8, 4 female, 4 male). Mice were genotyped by PCR analysis of tail DNA using standard methods. All experiments were conducted in accordance with the guidelines of the National Institutes of Health and were approved by the Nathan S. Kline Institute’s Institutional Animal Care and Use Committee.

Olfactory behavior test

Mice were screened for olfactory deficits using an odor-cross habituation test (Fig 1A)(Sundberg et al., 1982; Wilson and Linster, 2008). Odors (n=7; limonene, ethyl valerate, isoamyl acetate, pentanol, heptanone, propyl butyrate and nonane; Sigma Aldrich, St. Louis, MO) were diluted 1×10−3 in mineral oil and applied to a cotton-applicator stick which was then enclosed in a piece of odorless plastic tubing to prevent contact of the liquid odor with the testing chamber or animal yet still allow volatile odor delivery. Notably, such an odor presentation method controls for the influence of visual and/or somatosensory influences on odor investigation. Odors were delivered for 4 successive trials (1 block), 20sec each, separated by 30sec inter-trial intervals, by inserting the odor stick into a port on the side of the animal’s home cage (Fig 1A). Home cage testing was chosen over testing in a separate apparatus to minimize potential influences of stress and anxiety (due to the new environment/context) on the behavioral measures. Testing took place during the light phase of the animals’ (12:12) day: light cycle, over two daily sessions (3–4 odors/session) separated by 24–48 hrs. The duration of time spent investigating, defined as snout-oriented sniffing within 1cm of the odor presentation port, was recorded across all trials by a single observer blind to genotypes (D.W.W.). Home cages were cleaned with fresh corn cob bedding 24–48hrs prior to behavioral testing to reduce unnecessary background odors, yet still allowing for adaptation to the new bedding. The stainless steel food bin and water bottle were removed from cages immediately prior to testing.

Fig. 1
Progressive and age-dependent emergence of AD-like atypical olfactory behavior in APP transgenic mice

Histology

Tissue collection was performed following either urethane anesthesia (1mg/kg, IP) and transcardial perfusion with 10% formalin (3–4, 6–7 & 21–29mo old mice) or CO2 overexposure (16mo old mice; experimental constraints prevented the use of a single euthanasia agent for all groups). Mice were decapitated and brains rapidly removed over ice. Hemi-brains from 3–4, 6–7 and 21–29 month old mice were placed in 10% formalin for fixation. Hemi-brains from each animal were coronally sectioned (40μm) on a microtome. A subset of these sections were slide-mounted and immersed in a solution of filtered 1% Thioflavin-S for 10min (Sigma Aldrich), rinsed (×3) for 1min in ddH20 and subsequently cover-slipped with Vectashield hardmount with DAPI (4′,6-diamidino-2-phenylindole; Vector Laboratories, Inc., Burlingame, CA) for nuclear counter-stain. The remaining sections were left floating in tris-buffered saline (TBS) for 4G8 (anti-Aβ) immunohistochemistry (Mi et al., 2007). Sections were washed (3X @ 5min) in TBS after which they were treated with 85% formic acid for 5min to enhance amyloid staining. Sections were then washed in blocking buffer (0.05 M Tris-HCl pH 7.6, .9% NaCl, 0.25% Triton-X 100, 20% normal goat serum & 0.2% bovine serum albumin) 3X (10min each) before incubating for 12hrs in 4G8 primary antibody at 4° C (Signet Labs, Dedham, MA; 1:200 in blocking buffer). Sections were rinsed (3X @ 5min) in blocking buffer before incubating for 2hrs at room temperature in Alexa488 secondary antibody (Invitrogen, Carlsbad, CA). Finally sections were rinsed in TBS (3X @ 5min), placed on slides and cover-slipped with Vectashield hardmount with DAPI (Vector). Brains from all age-groups were stained during the same procedure and a positive control section (containing the hippocampus from a 16mo old Tg mouse) was placed on all slides of young (3–4 & 6–7mo old) mice. Optical scans of brain sections were collected within 7 days following staining by use of a Zeiss Axioscope microscope (model 200M) and a Zeiss digital camera (Carl Zeiss, Inc., Thornwood, NY). Sections were excited at 488nm and, due to the similar, yet still quantifiably different emission spectra of Thioflavin-S/Alexa488 and DAPI, emission from all fluorophores was captured with a FITC filter (Fluorescein-5-isothiocyanate).

Data analysis

For analysis of olfactory behavior data, all raw investigatory values (sec) were pooled within animals and organized according to odor presentation (trial) number. Due to separate groups of mice being used within each age group, 2-way ANOVAs versus repeated measured ANOVAs were used to examine the influence of age on behavior. First, as a measure of novel odor investigation, the durations of all trial 1 odor investigations were pooled within each genotype and age group and analyzed using 2-way ANOVAs for independent groups (8) followed by post-hoc group comparisons using Fisher’s PLSD. Second, as a measure of odor habituation, the raw investigatory values were normalized to the maximum investigatory duration per animal for each odor (max during trials 1–4). The maximum investigation duration was assigned a value of “1” and the lesser investigation times a proportion of 1. These normalized investigation probabilities of subjects for each odor were analyzed using 2-way ANOVAs for independent groups (8) and repeated measures (4 trials) within each group. Normalized odor investigation durations within individual trials were collapsed across all odors within groups across and analyzed using one-way ANOVAs for independent groups (8). Post-hoc group comparisons after a significant ANOVA result were made using Fishers PLSD tests. Finally, normalized investigation data were again used to determine effects of genotype on odor cross-habituation (discrimination). To calculate this ‘cross-habituation index’ (Rankin et al., 2009), the normalized investigatory values from all 4th trial odor presentations were subtracted from the following 1st trial odor presentations. These cross-habituation values were then analyzed using one-way ANOVAs for independent groups (4) followed by post-hoc group comparisons using Fisher’s PLSD.

Histological analysis of Aβ levels was performed in NIH ImageJ (http://rsbweb.nih.gov/ij). Six individual brain areas, the olfactory bulb (OB), orbitofrontal cortex (OFC), anterior (a-) and posterior piriform cortices (pPCX), dorsal hippocampus (Hipp) and lateral entorhinal cortex (Eth) were analyzed for levels of Thioflavin-S and anti-Aβ staining in order to quantity Aβ deposition (% area) across olfactory structures. Fluorescence levels of anti-Aβ 4G8 and Thioflavin-S were thresholded and regions of interest (ROIs) determined with the guidance of the DAPI counter stain and standard anatomical coordinates (Paxinos and Franklin, 2000).

Aβ deposition area (%) was quantified within each ROI separately. For measurements of Aβ deposition within the OB, individual layers were manually outlined using DAPI labeled anatomical layers as guides (See Fig 2A). The aPCX and pPCX were separated by the disappearance of the LOT (Fig 3A, dashed rectangle). Individual cell layers within the PCX were manually outlined using DAPI labeling as a guide. To quantify Aβ deposition in the OFC we selected a rectangular area within the medial OFC (Fig 4A, dashed region). We selected a diagonal rectangular area within the Eth to quantify Aβ deposition (Fig 4B, dashed region). To quantify Aβ deposition in the Hipp we manually outlined all Hipp regions (dentate, CA1, CA2 and CA3; Fig 4C, dashed region).

Fig. 2
Anti-Aβ, but not Thio-S positive Aβ is deposited early in life within the olfactory bulb
Fig. 3
Aβ levels are distributed throughout PCX cell layers
Fig. 4
Aβ deposition within higher-order olfactory regions

Aβ deposition (% area)(Mi et al., 2007) was defined as the cumulative area of fluorescent pixels above threshold within each ROI. At least 3 coronal brain sections (range 3–4) containing each ROI per mouse were used for analysis. Percent area values were in some cases analyzed using one-way ANOVAs for independent groups followed by post-hoc group comparisons using Fisher’s PLSD. Percent area values for each ROI within each section were treated as independent measures for analysis.

All statistical analyses were performed in StatVIEW (SAS Institute Inc., Cary, NC) or in MatLAB (The MathWorks Inc., Natick, MA). All values are reported as mean ± standard error of the mean (SEM) unless otherwise stated.

Results

Our primary goal was to establish whether there is a relationship between Aβ neuropathology and olfactory perception in the Tg2576 APP transgenic mouse model (Hsiao et al., 1996). We began to address this by examining odor-guided behavior in an odor cross-habituation task which allows for measurements of novel odor investigation, odor learning and memory (habituation) and odor discrimination (i.e., cross-habituation)–all within a single behavioral test. In this test, mice were presented in their home cages with cotton-applicator sticks laced with odor (see Methods & Fig 1A). Each odor was delivered across 4 successive trials (20sec duration, 30sec inter-trial interval (ITI)) and the duration of time spent investigating the odor was recorded across trials allowing quantification of novel odor investigation, odor habituation and odor cross-habituation (discrimination).

Habituation (and the generalization thereof, tested as cross-habituation) is a form of implicit or non-declarative memory, and is not hippocampus-dependent. One of the advantages of using odor habituation and cross-habituation as an assay in the present studies is that the synaptic mechanisms of short-term habituation (as tested here) are known. Short-term odor habituation is due to a metabotropic glutamate receptor-mediated, homo-synaptic depression of afferent synapses from the olfactory bulb in piriform cortex (Wilson and Linster, 2008). The odor specificity of this cortical adaptation is likely due to plasticity of intracortical association fiber synaptic plasticity within piriform cortex (Linster et al., 2009). Thus, while not a long-term memory task, odor habituation and its specificity allow assays of two very specific forms of synaptic plasticity and local circuit function that may be affected by AD related pathology.

Atypical novel odor investigation behavior in Tg2576 mice

We began our investigation into the possible olfactory deficits expressed by AD model mice by examining odor investigation behaviors in each age group of Tg2576 mice. The time spent investigating novel odors can be an indicator of arousal/motivation (Baum and Keverne, 2002) or habituation (Wilson and Linster, 2008). We pooled all novel (trial #1) odor investigation durations across all odors (n=7) and animals within each age group and genotype. As shown in Fig 1B, we found that 16 month and older (21–29mo) APP transgenic (Tg) mice investigated trial #1 odors longer than age-matched controls (WT). Analysis of variance (ANOVA) on all investigation times revealed a significant effect of genotype (F(1,272) = 66.4, p<.0001) and age (F(3,270) = 10.5, p<.0001). In particular, both 16 (F(1,87) = 36.7, p<.0001) and 21–29 month old Tg mice (F(1,95) = 88.4, p<.0001) investigated trial #1 odors significantly longer in comparison to WT mice (Fig 1B). To assess whether this tendency for aged Tg mice to investigate trial #1 odors for prolonged periods of time reflected simple hyperactivity and thus enhanced numbers of approaches to the odor port, in addition to total investigation duration, we also analyzed the number of sniff bouts. We found that 16 and 21–29 month old Tg mice displayed statistically similar numbers of sniff bouts in response to trial #1 odors (16mo: (Tg) 1.6±0.2, (WT) 1.6±0.1; 21–29mo (Tg) 1.8±0.2, (WT) 1.5±0.2. mean±SEM; 2-way ANOVA, p>.05 Tg vs. WT within each age) suggesting that the elevated odor investigation behavior displayed in 16 and 21–29 month old APP Tg mice reflects, at least within the context of this task, deficient short-term odor habituation.

Tg2576 mice fail to normally habituate to repeated odor exposure

Previous behavioral and physiological work has demonstrated that habituation to repeated odor exposure on a short-time scale (~30sec) is a process mediated by group III metabotropic glutamate receptors (mGluRIII)(Best and Wilson, 2004) located on presynaptic nerve terminals in the olfactory piriform cortex (PCX; (Wada et al., 1998)). Indeed, blocking mGluRIII receptors in vivo at the level of the PCX prevents cortical odor adaptation (Best and Wilson, 2004) and results in a failure to habituate normally to odor exposure (Yadon and Wilson, 2005). Since here we found that AD model mice possess different capacities to habituate to novel (trial #1) odors within a single 20sec exposure (Fig 1B), we next assessed odor habituation over repeated odor exposures in each of four age groups of mice. To do this, odor investigation durations across all trials (4 total, including the data from trial #1 (Fig 1B)) of the odor cross-habituation task were analyzed for differences between groups. Due to the significant differences shown in Fig 1B in the groups’ investigation levels within trial #1, all data were normalized before statistical analysis to the maximum odor investigation duration within each individual odor presentation block (trials #1–4, see Methods).

We found that, beginning at 3–4 months of age, APP Tg mice displayed an increased latency to habituate across odor presentations in comparison to age-matched WT controls (Fig 1C). Across all age-groups there was a significant overall genotype effect (F(1,266) = 98.2, p<.0001), an age effect (F(3,266) = 4.6, p<.005) and a significant interaction (F(3,266) = 18.2, p<.0001). Further, within each age-group there was a significant repeated measures effect (p<.0001). The significant effect of repeated measures indicated that all groups were eventually able to habituate to odors by the fourth trial, however, with slight differences among the groups (Fig 1C). WT mice in the 6–7, 16, and 21–29 month old age groups habituated more rapidly to odors in comparison to their age-matched Tg counterparts achieving statistical significance by the second trial ((6–7mo (F(1,37) = 22.4, p<.0001); 16mo (F(1,88) = 16.2, p<.0001; 21–29mo (F(1,94) = 73.7, p<.0001)). We revealed a similar effect by examining for genotype differences of complete habituation abilities (i.e., ‘habituation difference’, see Methods) across all 4 trials by subtracting the normalized investigation duration during trial #4 from the maximum normalized investigation duration within that block (Fig 1C). Indeed, even at our earliest time point, 3–4 months, the habituation index was 0.08 (i.e., 8% difference between WT and Tg mice in habituation abilities). This habituation deficit in Tg mice increased in 6–7 month old mice (31% difference with WT), and was maintained at both the 16 and 21–29 month old age points (Fig 1C)–demonstrating that atypical habituation to repeated odor exposure begins early in life in the Tg2576 mouse model and is maintained throughout life.

Reduced odor discrimination in Tg2576 mice

As a final behavioral measure we assessed odor discrimination abilities across age in APP Tg mice. Odor cross-habituation–the response difference between a habituated odor and a newly presented odor–can be used as a test of spontaneous odor discrimination (Linster et al., 2002; Wesson et al., 2008) which eliminates the confounds associated with traditional operant odor discrimination tests (e.g., nutritional deprivation, sensorimotor control). A strong investigation of a novel odor following the presentation of a habituated odor (i.e., minimal cross-habituation) reflects discrimination of the two odors whereas no or a weak investigation (i.e., strong cross-habituation) reflects generalization or a failure to discriminate (Wilson and Linster, 2008; Rankin et al., 2009). To our knowledge, no data are currently available on odor discrimination abilities in any line of AD model mice.

Therefore, to characterize odor discrimination abilities in Tg2576 mice, we analyzed the same odor cross-habituation data used for Figs 1B–1C, but this time directly for odor cross-habituation. In particular, we compared across all trials, the difference in duration of investigating all novel odors (trial #1) from the previous trial #4. Due to differences in odor investigation in trial #1, normalized odor investigation data (as in Fig 1C) were used. The investigation value for the preceding trial #4 was subtracted from the novel odor trial (trial #1) to calculate a ‘cross-habituation index’. Similar measures of cross-habituation as an index for stimulus discrimination are commonly utilized across a variety of sensory paradigms (Rankin et al., 2009).

We found that Tg2576 mice showed reduced odor discrimination abilities (enhanced generalization) when compared to age-matched WT controls (Fig 1D). Further, similar to measures of odor habituation, deficits in odor discrimination were evident by 6–7 months of age. ANOVA on all cross-habituation values revealed a significant effect of genotype (F(1,223) = 74.6, p<.0001) on odor cross-habituation. There was a significant reduction in odor cross-habituation in 6–7 (F(1,29) = 8.96, p=.0056), 16 (F(1,71) = 14.77, p=.0003) and 21–29 (F(1,81) = 222.0, p<.0001) months old Tg mice in comparison to controls (Fig 1D). These results suggest that fine aspects of odor information processing in Tg2576 mice may be altered in a manner sufficient to yield deficiencies in odor discrimination and odor learning.

Differential elevations in Aβ throughout the olfactory system during aging

Characterization of Aβ deposition throughout the olfactory processing stream in AD model mice, paired with perceptual data, would be valuable in understanding the pathological determinants of olfactory dysfunction in AD. For instance, are Aβ levels related to olfactory dysfunction in a dose-dependent manner? Further, given the differential expression of atypical olfactory behaviors throughout the lifespan reported here (Fig 1), do increases in Aβ within certain olfactory regions temporally correspond with the emergence of these behaviors? Therefore, we characterized Aβ levels throughout the olfactory system of mice previously tested in odor cross-habituation with 2 separate methods (see Methods)–Thioflavin-S labeling of β-pleated sheet confirmation of proteins, including fibrilar Aβ deposits, and immunostaining with anti-Aβ antibody (4G8) against all Aβ forms including fibrillar and non-fibrillar deposits and also other metabolites of APP and APP itself.

The first step in odor information processing occurs within the OB when olfactory receptor neurons project into the glomerular layer (Gl). As shown in Fig 2A, beneath the Gl there are 4 layers, including, the external plexiform layer (Epl), the mitral/tufted cell layer (MT), the inner plexiform layer (Ipl) and finally within the center of the OB is the granule cell layer (Grl). All layers of the OB are essential in odor information processing (Wachowiak and Shipley, 2006). Using 4G8 (anti-Aβ) and Thioflavin-S markers, we observed age-dependent Aβ deposition within particular layers of the OB (Figs 2B & C). First, in young mice (3–4mo) we found anti-Aβ-positive Aβ deposits within the Gl (Figs 2B & C). After 6–7 months of age, this type of Aβ deposition increased across the other OB cell layers (Figs 2B & C). In contrast, there was a complete absence of Thio-S -positive amyloid deposits in the OBs of 3–4 mo old Tg mice (Fig 2B). At 6–7 months of age, some animals (n=2/5) displayed sparse (i.e., 1–2 in a given brain section) Thio-S -positive amyloid deposits in the Grl (Fig 2B). Notably, Aβ deposition at this age in the OB precedes previous reports of plaque deposition in the hippocampus and neocortex ((Hsiao et al., 1996; Kawarabayashi et al., 2001) also see Fig 4B). Within both the 16 and 21–29 month old Tg mice, the Grl was strongly burdened with Thio-S -positive Aβ plaques (Figs 2B & C). Interestingly, we found that Thio-S -positive amyloid plaques were localized almost exclusively within the Grl of Tg2576 mice. Only rarely were any Thio-S–positive Aβ deposits observed within the Gl, Epl, MT or Ipl (Fig 2D). These data demonstrate a unique property for the OB Grl to host Thio-S -positive Aβ plaque deposition, despite the prevalence of anti-Aβ-positive deposition across other layers of the OB. Further, these data suggest a broad range of potential contributors to the olfactory behavioral phenotype of the Tg2576 mouse, including, Thio-S positive Aβ plaque deposition in the Grl or potentially anti-Aβ-positive deposition across all cell layers.

Beyond the OB, MT axons fasciculate to form the lateral olfactory tract (LOT) which projects into the piriform cortex (PCX). LOT axons terminate within superficial layer I where they synapse onto pyramidal cells with soma in layers II and III. Layer II/III pyramidal cells extend basal dendrites into layer III where feedback and association fiber connections further process olfactory information (Haberly, 2001). Recent evidence suggests a strong role for the anterior PCX (aPCX, Fig 3A top) in odor identification and for posterior PCX (pPCX, Fig 3A bottom) in odor quality encoding (Gottfried et al., 2006; Kadohisa and Wilson, 2006b). Further, disruption of PCX activity impairs odor discrimination and learning (i.e., habituation)(Wilson et al., 2006). Whereas we found that the LOT was spared of Aβ deposition (Thio-S and anti-Aβ, data not shown) we observed Aβ deposition, at differing levels, throughout all layers of the aPCX and pPCX. In general, layer III of both the aPCX and pPCX developed the greatest density of Aβ burden of all 3 layers (Figs 3B and and3C).3C). In contrast, layer II of aPCX had the least Aβ burden. Further, Aβ deposition within the PCX did not become apparent until 16 months of age. Across all layers, anti-Aβ deposition was greater than Thio-S -positive Aβ deposition alone (Fig 3C). These data, showing that Aβ does not escalate in the PCX until 16 months of age, reveal, at least within this APP transgenic model, that the PCX is impacted by Aβ neuropathology later in life than the OB. Further, PCX Aβ levels do not predict the occurrence of atypical odor habituation nor discrimination, as these behaviors emerged at 6–7 months of age. However, Aβ elevation at 16 months in the PCX did coincide with the emergence of atypical odor investigation behavior (PCX-dependent short-term habituation (Wilson and Linster, 2008), Fig. 1B).

We also extended our analysis of Aβ deposition into three ‘higher-order’ olfactory regions. The orbitofrontal cortex (OFC) is located within the frontal cortex (Fig 4A) and has reciprocal connections with the PCX (Illig, 2005). As shown in Fig 4A we found Aβ deposition within the OFC starting with the 16 month age group. Further, these Aβ levels increased into the 21–29 month age group, with the greatest escalation in anti-Aβ-positive deposition (Fig 4A). Aβ deposits within the OFC were similar in density as in neighboring frontal cortex regions suggesting that the OFC is not particularly affected by Aβ pathology as was the case for the OB Grl and layer III of the PCX. The lateral entorhinal cortex (Eth) is located posterior to the pPCX (Fig 4B) and receives small but direct MT cell input from the OB, as well as input from PCX (Schwob and Price, 1978). Further, the Eth is involved in olfactory memory (Eichenbaum et al., 1994). We found relatively dense Aβ deposition (both Thio-S and anti-Aβ-positive) within the Eth of Tg2576 mice starting at 16 months of age group (Fig 4B). As was the case for the OFC, regions neighboring the Ent displayed qualitatively similar levels of Aβ deposition. Finally, the dorsal hippocampus (Hipp) is also involved in olfactory memory and receives olfactory-related input form the Eth (Staubli et al., 1984)(Fig 4C). Similar to previous reports (Hsiao et al., 1996), the Hipp was particularly affected by Aβ deposition (Fig 4C). Aβ deposition was evident starting in the 16 month age group and progressed in levels into the 21–29 month group. Together, these results suggest that Aβ (deposition) pathology has the potential to impact olfactory processing across multiple brain areas.

To provide contrast to Aβ deposition levels within brain regions unique to olfactory processing, we also measured Aβ deposition within the primary somatosensory and motor cortices (cumulative % area in S1 and M1, see Methods). Similar to that found in the PCX, OFC, Ent and Hipp, Aβ deposition did not become evident in the S1/M1 until 16 months of age (% area anti-Aβ at 3–4mo: 0.01±0.01, 6–7mo: 0.1±0.03, 16mo: 0.4±0.2 & 21–29mo: 5.5±0.6; % area Thio-S at 3–4mo: 0±0, 6–7mo: 0±0, 16mo: 0.7±0.1 & 21–29mo: 4.8±0.5; mean±SEM). Within animals, Aβ deposition was notably greater within principal olfactory areas (OB and PCX) than in S1/M1 (see Figs 2 & 3).

Atypical olfactory behaviors indicate early-life elevations in Aβ aggregation

We observed Aβ deposition across the majority of olfactory structures examined (Figs 24). Therefore, we next asked whether Thio-S and anti-Aβ–positive deposits correlate with the age-dependent olfactory behavioral deficits found in Tg2576 mice. To do this we took the average % Aβ values (Thioflavin S & anti-Aβ-positive separately, as shown in Figs 24) from the OB, PCX, OFC, Ent & Hipp within individual animals (all age-groups) previously tested on olfactory cross-habituation test (Fig 1). As shown in Fig 5, behavioral deficits (investigation, habituation & discrimination) significantly correlated (r>0.37; n=22 mice, df=20), in some cases highly, with both Thio-S and anti-Aβ-positive Aβ burden. For example, abnormal odor investigation behaviors highly correlated with Thio-S -positive deposits in the Ent (r=0.75) and with anti-Aβ deposits in the OB (r=0.72). Odor discrimination abilities were significantly correlated with anti-Aβ deposits in the PCX (r=0.75) and Ent (r=0.43) and with Thio-S -positive deposits in the Hipp (r=0.44), but with neither markers in the OB (r<0.25). Odor habituation abilities were significantly correlated with Thio-S -positive deposition in the Hipp (r=0.46) and Ent (r=0.48) and with anti-Aβ deposition in the Ent (r=0.42) and PCX (r=0.36; Fig 5). In contrast to previous reports suggesting that olfactory dysfunction is related to altered top-down modulation of odor processing (Guérin et al., 2009), our data revealing associations between Aβ deposition and olfactory dysfunction supports a potential link between Aβ within specific areas of the primary olfactory network and some aspects of olfactory behavior (see Fig 6).

Fig. 5
Olfactory behaviors correlate with the spatio-temporal deposition of Aβ
Fig. 6
Summary diagram showing the emergence of atypical olfactory behaviors in relation to Aβ deposition levels

Discussion

The present results demonstrate that Tg2576 mice present with progressive olfactory impairments compared to age-matched WT controls. The Tg2576 mice behavioral deficits included 1) perseveration of initial odor investigation, 2) impaired short-term odor habituation and 3) impaired odor discrimination. Furthermore, detailed analysis of fibrillar (Thio-S positive) and fibrillar and/or non-fibrillar Aβ burden (anti-Aβ positive) throughout major olfactory processing centers revealed that the emergence of specific behavioral impairments corresponds with a progressive Aβ burden in specific olfactory regions. For example, while deficits in initial odor investigation strongly correlated with non-fibrillar Aβ deposits within the OB, odor discrimination deficits were correlated with non-fibrillar Aβ deposits within PCX, but not OB. Finally, the earliest detectable olfactory deficits emerged as early as 3 months of age, the same age as emergence of initial non-fibrillar Aβ deposits within the first synaptic layer of the OB. Together, these findings provide both a spatial and temporal correlation between specific olfactory deficits and localize Aβ neuropathology within the olfactory system (Fig 6).

Tg2576 mice express an APP mutation (KM670/671NL), possess elevated soluble Aβ in the neocortex at 7 months of age (Kawarabayashi et al., 2001), and start displaying fibrillar Aβ deposits in the hippocampus and neocortex around 10 months of age (Hsiao et al., 1996; Kawarabayashi et al., 2001). Aβ plaques have been reported in the OBs of aged Tg2576 mice (Lehman et al., 2003) and humans with AD (Kovacs, 2004). However, no detailed characterization of Aβ deposition within the OB nor throughout the olfactory system has been performed in either humans or AD model mice. Our analysis of Aβ throughout the Tg2576 mouse olfactory system revealed differences both within and between olfactory structures in Aβ deposition. While several studies to date have demonstrated that APP and/or Aβ serve to modulate synaptic processing of neural activity (Kamenetz et al., 2003; Puzzo et al., 2008), whether Aβ or the over production of other APP processing fragments in these mice (e.g., C-terminal fragments (Gao and Pimplikar, 2001)) perturb network processing of information in the brain is currently not well understood. Indeed, measuring factors other than deposited Aβ may be important in understanding the relationship between AD pathology and the observed olfactory impairments. For example, soluble oligomeric forms of Aβ are important in mediating AD-like neurodegeneration (Varvel et al., 2008) and in modulating synaptic activity (Haass and Selkoe, 2007). Thus, while the present findings show strong relationships between both fibrilar and non-fibrilar Aβ deposits and atypical olfactory behaviors, they suggest that non-fibrillar forms of Aβ provide unique insights into the basis of olfactory dysfunction in AD. Further, future studies into the potential contributions of other AD pathologies (e.g., NFTs) in combination with Aβ deposition to the emergence of AD-related sensory loss may provide important insights into disease pathogenesis and allow additional understandings as to the cause of olfactory sensory loss in AD.

The neural mechanisms which govern odor information processing in mammals are fairly well understood (Wilson and Stevenson, 2006). Such mechanisms are essential in informing perception and guiding olfactory behaviors. In the present study we used the odor cross-habituation task which takes advantage of the natural tendencies of mice to investigate novel odors (Sundberg et al., 1982). This test is less labor intensive than Morris water maze and both less invasive and less labor intensive than fear learning paradigms. The design of the cross-habituation task allowed us to assay 3 separate aspects of olfaction in the Tg2576 mouse, including novel odor orienting responses, short-term odor memory (habituation) and odor discrimination. This test will be highly advantageous in testing the efficacy of treatment against APP and/or Aβ related-abnormalities in AD mouse models.

Upon the detection of a novel odor in their environment, rats and mice reliably display an arousal-related orienting response involving sniffing and whisker movements in the direction of the odor. Such orienting responses are mostly utilized for the acquisition of odor information (Wachowiak, 2009). Indeed, a single sniff of an odor is sufficient to yield even complex odor detection and discrimination (Wesson et al., 2008)–arguing that prolonged rapid frequency sniffing (as seen in orienting responses) is not necessary to discriminate odors. Instead, the duration of this odor investigation behavior is dependent on arousal, motivation, and past experience (Wachowiak, 2009). Short-term habituation (decrease over repeated presentations (Rankin et al., 2008)) to odors is associated with receptor neuron adaptation (Reisert and Matthews, 2001; Verhagen et al., 2007), OB mitral cell adaptation (Kadohisa and Wilson, 2006a), and PCX adaptation (Wilson, 1998; Kadohisa and Wilson, 2006a). Despite these widespread factors, the primary contributor to short-term habituation is PCX adaptation, mediated by depression of mitral pyramidal cell synapses within Layer I of the PCX (Best and Wilson, 2004).

In particular, it is worth noting that PCX Layer I, especially within the pPCX, had a high level of Aβ deposition. Given the importance of Layer I synapses in short-term odor habituation, it is possible that the deficits in short-term odor habituation observed in Tg2576 mice were related to Aβ-mediated mechanisms directly within layer I sensory processing. This hypothesis is supported by the fact that Aβ deposition in the PCX was apparent in 16 month old mice, but not in 6–7 month old mice–corresponding with the emergence in atypical short-term odor habituation (trial #1 odor investigation). Further, anti-Aβ staining was prevalent within the OB Gl layer starting at 3 months of age–which corresponds with the emergence of atypical odor habituation. The Gl is a crucial site for the initial processing of odor input from receptor neurons in the nasal cavity (Wachowiak and Shipley, 2006). Thus, it is possible that non-fibrillar Aβ acts directly upon sensory neuron terminals within the Gl to modulate synaptic processing of odor information at the earliest level. Future studies will be important to examine these hypotheses.

Odor discrimination relies on olfactory receptor neuron function (Wachowiak and Shipley, 2006), local circuit function within the olfactory bulb (Beshel et al., 2007; Doucette et al., 2007), and pattern recognition and template formation of previously experienced odors within the PCX (Barnes et al., 2008). OB local circuit function, including granule cell-mediated feedback and lateral inhibition, is believed to contribute to contrast enhancement between similar odors (Wachowiak and Shipley, 2006; Wilson and Mainen, 2006). Notably, previous work has shown that the cross-habituation assay is sensitive to even slight differences in odor structure (Fletcher and Wilson, 2002). Association fiber plasticity within PCX layers I and III are believed to be critical for recognition and discrimination of those odor-evoked spatiotemporal patterns of OB activity (Haberly, 2001). Thus, Aβ burden in either the OB or PCX could contribute to the observed odor discrimination deficits. As atypical odor discrimination emerged prior to Aβ deposition in the PCX, it is possible that the sparse Aβ deposition within the OB Gl (as in Fig 2) is responsible for the deficits in odor discrimination. In support of this, here we found that the 6–7 month old Tg2576 mice which had Aβ deposits in the OB had more predominant olfactory dysfunction than the mice that did not (as reflected through the correlations, Fig 5). Alternatively, maladaptive olfactory processing may arise within regions/layers neighboring these important layers (Liu et al., 2008). It will be important in future studies to determine the contributions of Aβ within each of these structures, independently, to the cellular processing of odor information.

In summary, our findings provide initial insights into the pathological basis of AD-related olfactory dysfunction. In particular, our data revealed a correlation between the magnitude and occurrence olfactory deficits and the spatial-temporal pattern of Aβ deposition. Also at 3 months of age we observed non-fibrillar Aβ deposition within the olfactory bulb earlier than deposition within any other brain region. Therefore, these data suggest that non-fibrillar, versus fibrillar Aβ-related mechanisms likely contribute to early olfactory perceptual loss in Alzheimer’s disease.

Acknowledgments

This work was supported by grants DC003906 to D.A.W and AG017617 to R.A.N. from the National Institutes of Health and grant IIRG0759699 from the Alzheimer’s Association to E.L. We thank Drs. Gurjinder Kaur for advice with amyloid measurements, Monika Pawlik for assistance with mice breeding & genotyping and Dun-Sheng Yang for thoughtful discussions regarding this project.

Footnotes

Author contributions: D.W.W. & D.A.W. conceived of the project. E.L. & R.N. contributed valuable advice. D.W.W. collected and analyzed data. All authors discussed the results, their implications and contributed to manuscript preparation.

References

  • Albers M, Tabert M, Devanand D. Olfactory dysfunction as a predictor of neurodegenerative disease. Curr Neurol Neurosci Rep. 2006;6:379–386. [PubMed]
  • Alzheimer A, Stelzmann R, Schnitzlein H, Murtagh F. An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde” Clinical Anatomy. 1907;8:429–431. [PubMed]
  • Barnes DC, Hofacer RD, Zaman AR, Rennaker RL, Wilson DA. Olfactory perceptual stability and discrimination. Nat Neurosci. 2008;11:1378–1380. [PMC free article] [PubMed]
  • Baum MJ, Keverne EB. Sex difference in attraction thresholds for volatile odors from male and estrous female mouse urine. Hormones and Behavior. 2002;41:213–219. [PubMed]
  • Beshel J, Kopell N, Kay LM. Olfactory bulb gamma oscillations are enhanced with task demands. J Neurosci. 2007;27:8358–8365. [PubMed]
  • Best AR, Wilson DA. Coordinate Synaptic Mechanisms Contributing to Olfactory Cortical Adaptation. J Neurosci. 2004;24:652–660. [PMC free article] [PubMed]
  • Doucette W, Milder J, Restrepo D. Adrenergic modulation of olfactory bulb circuitry affects odor discrimination. Learning & Memory. 2007;14:539–547. [PMC free article] [PubMed]
  • Eichenbaum HB, Otto T, Cohen NJ. Two functional components of the hippocampal memory system. Behav Brain Sci. 1994;17:449–472.
  • Fletcher ML, Wilson DA. Experience modifies olfactory acuity: acetylcholine-dependent learning decreases behavioral generalization between similar odorants. J Neurosci. 2002;22:RC201. [PMC free article] [PubMed]
  • Gao Y, Pimplikar SW. The γ-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc Natl Acad Sci USA. 2001;98:14979–14984. [PMC free article] [PubMed]
  • Gottfried JA, Winston JS, Dolan RJ. Dissociable codes of odor quality and odorant structure in human piriform cortex. Neuron. 2006;49:467–479. [PubMed]
  • Guérin D, Sacquet J, Mandairon N, Jourdan F, Didier A. Early locus coeruleus degeneration and olfactory dysfunctions in Tg2576 mice. Neurobiology of Aging. 2009;30:272–283. [PubMed]
  • Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid [beta]-peptide. Nat Rev Mol Cell Biol. 2007;8:101–112. [PubMed]
  • Haberly LB. Parallel-distributed Processing in Olfactory Cortex: New Insights from Morphological and Physiological Analysis of Neuronal Circuitry. Chem Senses. 2001;26:551–576. [PubMed]
  • Hardy J, Selkoe DJ. The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics. Science. 2002;297:353–356. [PubMed]
  • Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99–102. [PubMed]
  • Illig KR. Projections from orbitofrontal cortex to anterior piriform cortex in the rat suggest a role in olfactory information processing. J Comp Neurol. 2005;488:224–231. [PMC free article] [PubMed]
  • Kadohisa M, Wilson DA. Olfactory Cortical Adaptation Facilitates Detection of Odors Against Background. J Neurophysiol. 2006a;95:1888–1896. [PMC free article] [PubMed]
  • Kadohisa M, Wilson DA. Separate encoding of identity and similarity of complex familiar odors in piriform cortex. Proc Natl Acad Sci U S A. 2006b;103:15206–15211. [PMC free article] [PubMed]
  • Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R. APP processing and synaptic function. Neuron. 2003;37:925–937. [PubMed]
  • Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG. Age-Dependent Changes in Brain, CSF, and Plasma Amyloid {beta} Protein in the Tg2576 Transgenic Mouse Model of Alzheimer’s Disease. J Neurosci. 2001;21:372–381. [PubMed]
  • Kovacs T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Research Reviews. 2004;3:215–232. [PubMed]
  • Lee VM, Goedert M, Trojanowski JQ. NEURODEGENERATIVE TAUOPATHIES. Annual Review of Neuroscience. 2001;24:1121–1159. [PubMed]
  • Lehman EJ, Kulname LS, Lamb BT. Alterations in beta-amyloid production and deposition in brain regions of two transgenic models. Neurobio of Aging. 2003;24:645–653. [PubMed]
  • Linster C, Menon AV, Singh CY, Wilson DA. Odor-specific habituation arises from interaction of afferent synaptic adaptation and intrinsic synaptic potentiation in olfactory cortex. Learning & Memory. 2009;16:452–459. [PMC free article] [PubMed]
  • Linster C, Johnson BA, Morse A, Yue E, Leon M. Spontaneous versus reinforced olfactory discriminations. J Neurosci. 2002;22:6842–6845. [PubMed]
  • Liu Y, Yoo M-J, Savonenko A, Stirling W, Price DL, Borchelt DR, Mamounas L, Lyons WE, Blue ME, Lee MK. Amyloid Pathology Is Associated with Progressive Monoaminergic Neurodegeneration in a Transgenic Mouse Model of Alzheimer’s Disease. J Neurosci. 2008;28:13805–13814. [PubMed]
  • Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in Neurodegenerative Disease: A Meta-analysis of Olfactory Functioning in Alzheimer’s and Parkinson’s Diseases. Arch Neurol. 1998;55:84–90. [PubMed]
  • Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, Sommer J, Schmidt SD, Nixon RA, Mathews PM, Levy E. Cystatin C inhibits amyloid-[beta] deposition in Alzheimer’s disease mouse models. Nat Genet. 2007;39:1440–1442. [PubMed]
  • Montgomery KS, Simmons RK, Edwards G, III, Nicolle MM, Gluck MA, Myers CE, Bizon JL. Novel age-dependent learning deficits in a mouse model of Alzheimer’s disease: Implications for translational research. Neurobiology of Aging. 2009 In Press, Corrected Proof. [PubMed]
  • Murphy C. Loss of Olfactory Function in Dementing Disease. Physiology & Behavior. 1999;66:177–182. [PubMed]
  • Paxinos G, Franklin K. The Mouse Brain in Stereotaxic Coordinates. 2. San Diego: Academic Press; 2000.
  • Price J, Davis P, Morris J, White D. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease. Neurobiology of Aging. 1991;12:295–312. [PubMed]
  • Puzzo D, Privitera L, Leznik E, Fa M, Staniszewski A, Palmeri A, Arancio O. Picomolar Amyloid-{beta} Positively Modulates Synaptic Plasticity and Memory in Hippocampus. J Neurosci. 2008;28:14537–14545. [PMC free article] [PubMed]
  • Rankin CH, Abrams T, Barry RJ, Bhatnagar S, Clayton DF, Colombo J, Coppola G, Geyer MA, Glanzman DL, Marsland S, McSweeney FK, Wilson DA, Wu CF, Thompson RF. Habituation revisited: An updated and revised description of the behavioral characteristics of habituation. Neurobiol Learn Mem Epub 2008 [PMC free article] [PubMed]
  • Rankin CH, Abrams T, Barry RJ, Bhatnagar S, Clayton DF, Colombo J, Coppola G, Geyer MA, Glanzman DL, Marsland S, McSweeney FK, Wilson DA, Wu C-F, Thompson RF. Habituation revisited: An updated and revised description of the behavioral characteristics of habituation. Neurobiology of Learning and Memory. 2009;92:135–138. [PMC free article] [PubMed]
  • Reisert J, Matthews HR. Response properties of isolated mouse olfactory receptor cells. J Physiol. 2001;530:113–122. [PMC free article] [PubMed]
  • Schwob JE, Price JL. The cortical projection of the olfactory bulb: development in fetal and neonatal rats correlated with quantitative variations in adult rats. Brain Res. 1978;151:369–374. [PubMed]
  • Selkoe DJ. Soluble oligomers of the amyloid [beta]-protein impair synaptic plasticity and behavior. Behavioural Brain Research. 2008;192:106–113. [PMC free article] [PubMed]
  • Staubli U, Ivy G, Lynch G. Hippocampal denervation causes rapid forgetting of olfactory information in rats. Proceedings of the National Academy of Sciences of the United States of America. 1984;81:5885–5887. [PMC free article] [PubMed]
  • Sundberg H, Doving K, Novikov S, Ursin H. A method for studying responses and habituation to odors in rats. Behavioral and Neural Biology. 1982;34:113–119. [PubMed]
  • Van Dijck A, Vloeberghs E, Van Dam D, Staufenbiel M, De Deyn PP. Evaluation of the APP23-model for Alzheimer’s disease in the odour paired-associate test for hippocampus-dependent memory. Behavioural Brain Research. 2008;190:147–151. [PubMed]
  • Varvel NH, Bhaskar K, Patil AR, Pimplikar SW, Herrup K, Lamb BT. A{beta} Oligomers Induce Neuronal Cell Cycle Events in Alzheimer’s Disease. J Neurosci. 2008;28:10786–10793. [PMC free article] [PubMed]
  • Verhagen JV, Wesson DW, Netoff TI, White JA, Wachowiak M. Sniffing controls an adaptive filter of sensory input to the olfactory bulb. Nat Neurosci. 2007;10:631–639. [PubMed]
  • Wachowiak M. Active Sensing in Olfaction. In: Simon SA, Nicolelis MA, editors. The Neurobiology of Olfaction. 1. CRC; 2009. p. 442.
  • Wachowiak M, Shipley MT. Coding and synaptic processing of sensory information in the glomerular layer of the olfactory bulb. Semin Cell Dev Biol. 2006;17:411–423. [PubMed]
  • Wada E, Shigemoto R, Kinoshita A, Ohishi H, Mizuno N. Metabotropic glutamate receptor subtypes in axon terminals of projection fibers from the main and accessory olfactory bulbs: A light and electron microscopic immunohistochemical study in the rat. The Journal of Comparative Neurology. 1998;393:493–504. [PubMed]
  • Wesson DW, Carey RM, Verhagen JV, Wachowiak M. Rapid encoding and perception of novel odors in the rat. PLoS Biol. 2008;6:e82. [PMC free article] [PubMed]
  • Wilson DA. Habituation of Odor Responses in the Rat Anterior Piriform Cortex. J Neurophysiol. 1998;79:1425–1440. [PubMed]
  • Wilson DA, Stevenson RJ. Olfactory perception from neurobiology to behavior. The Johns Hopkins University Press; 2006. Learning to smell.
  • Wilson DA, Linster C. Neurobiology of a Simple Memory. J Neurophysiol. 2008;100:2–7. [PubMed]
  • Wilson DA, Kadohisa M, Fletcher ML. Cortical contributions to olfaction: plasticity and perception. Semin Cell Dev Biol. 2006;17:462–470. [PubMed]
  • Wilson RI, Mainen ZF. Early events in olfactory processing. Annu Rev Neurosci. 2006;29:163–201. [PubMed]
  • Yadon CA, Wilson DA. The role of metabotropic glutamate receptors and cortical adaptation in habituation of odor-guided behavior. Learn Mem. 2005;12:601–605. [PMC free article] [PubMed]
  • Young J, Sharkey J, Finlayson K. Progressive impairment in olfactory working memory in a mouse model of Mild Cognitive Impairment. Neurobiology of Aging. 2009;30:1430–1443. [PubMed]
  • Zhuo JM, Prakasam A, Murray ME, Zhang HY, Baxter MG, Sambamurti K, Nicolle MM. An increase in Abeta42 in the prefrontal cortex is associated with a reversal-learning impairment in Alzheimer’s disease model Tg2576 APPsw mice. Curr Alzheimer Res. 2008;5:385–391. [PubMed]
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...